Wegener's granulomatosis is a systemic necrotizing granulomatous vasculitis of small-to medium-sized vessels typically affecting upper and lower airways, lungs, and kidneys. Cardiac involvement is less common and conducting tissue involvement is extremely rare. Cardiac manifestations are often not clinically apparent, but are associated with increased mortality. We report the case of a 36-year-old female with Wegener's thought to be in remission, presenting in complete atrioventricular (AV) block, with echocardiographic evidence of basal interatrial septum and basal lateral left atrial wall thickening. Despite immunosuppression therapy a permanent pacemaker was required for recurring complete AV block. Although rare, this case emphasizes the need for careful and regular screening for cardiac involvement in this multi-system condition.
Introduction
Wegener's granulomatosis is a systemic necrotizing granulomatous vasculitis of small-to medium-sized vessels associated with diffuse cytoplasmic anti-neutrophil cytoplasmic antibodies (cANCA) specific for proteinase-3 (PR3). It typically affects the upper and lower airways, lungs, and kidneys. Less commonly, cardiac involvement manifests in 6-25% of unselected patients with Wegener's granu-lomatosis, and up to 44% of patients with severe renal involvement, usually as pericarditis, myocarditis, and aortitis, although myocardial infarction is also recognized [1] . Cardiac conducting tissue involvement is extremely rare. Although often not clinically apparent, cardiac involvement is associated with increased mortality [2] . We report a case of complete atrioventricular block in a patient with Wegener's granulomatosis thought to be in remission, and review the current literature.
Case report
A 36-year-old woman with a three-month history of presyncopal symptoms presented with two syncopal episodes in May 2010. At the initial presentation her electrocardiogram showed sinus rhythm with first degree atrioventricular (AV) block and a PR interval of 250 ms. Overnight monitoring did not reveal any other abnormality and she was discharged with plans for further outpatient cardiac investigation. Six days later she re-presented with a second episode of syncope and at this time electrocardiogram showed complete AV dissociation with a ventricular rate of 28 beats per minute (Fig. 1) . No other symptoms or signs of systemic illness were elicited.
In June 2008 she had been diagnosed with Wegener's granulomatosis after presenting with a two-week history of nasal crusting, loss of hearing, polyarthralgia, and small-vessel ischemia of the fingers and toes. At that time erythrocyte sedimentation rate (ESR) was 86 mm/h, C-reactive protein (CRP) 140 mg/l, and cANCA immunofluorescence was positive with anti-PR3 titre of 103 units (normal range 0-7 units) by enzyme-linked immunosorbent assay. An electrocardiogram had been performed showing sinus rhythm with a normal PR interval and QRS duration, but regrettably no other cardiac investigation, including echocardiography, had been undertaken at the time of first diagnosis. She was treated with high-dose steroids, cyclophosphamide, prostacyclin, and co-trimoxazole. Clinical and laboratory remission was achieved by September 2008, and she was maintained on azathioprine therapy.
At the time of this admission, her inflammatory markers were mildly elevated (ESR of 19 mm/h and CRP of 23 mg/l) and the anti-PR3 titre was normal (4.5 units). Serum potassium was increased at 7 mmol/l with a creatinine of 118 mol/l, without erythrocyturia, urinary casts, or proteinuria. Although she initially settled into a sinus rhythm with first-degree AV block following correction of her hyperkalaemia, complete AV block recurred the next day despite normal electrolyte levels.
A transthoracic echocardiogram showed markedly thickened basal segments of her left atrium, including the basal interatrial septum (Figs. 2 and 3) . Left ventricular chamber size and wall thickness were normal, with normal systolic and diastolic function. It was felt, given the raised inflammatory markers, that she may have active granulomatous disease affecting the region of the atrioventricular node and she was treated with intravenous methylprednisolone and cyclophosphamide. Despite this, she continued to experience symptomatic high-grade AV block with prolonged episodes of ventricular standstill and so a dual chamber pacemaker was implanted.
At three-month follow-up she remained asymptomatic. However, her transthoracic echocardiographic appearances were essentially unchanged and she had been pacing dependent for 85% of the time in the month up to review.
Discussion
Cardiac involvement of Wegeners's granulomatosis was first reported by Wegener in 1936, but the first case of associated complete AV block did not appear until 1969 [3] . Since then, there have only been 13 cases previously reported in the published literature and all but one case was associated with systemic disease (Table 1) [1, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Complete AV block was present at disease onset in 50% and in 70% by one year. Half the cases were asymptomatic, although all had clinical or laboratory evidence of active disease. Echocardiograms were performed in nine of the patients and abnormalities were present in six; most commonly valvular abnormalities and pericardial effusion. This is in keeping with a review of echocardiography in 85 patients with confirmed Wegener's granulomatosis finding abnormalities in 86% [2] . Treatment included corticosteroids, cyclophosphamide, temporary pacing wire, and pacemaker implantation. The complete AV block resolved in 9 of the 13 cases. Two patients died of cardiac dysrhythmia, neither of which had been treated with cyclophosphamide. Postmortem examination of the first case reported by Longauer et al. showed granulomatous involvement of the conduction system with fibrosis and hyalinization, but not necrosis [3] . In the second case, Ohkawa et al. reported small foci of inflammation affecting the sinus and AV nodes with AV nodal arteritis, inflammatory necrotising granulomatous involvement of the conducting system, and myocardium associated with an exudative endocarditis and fibrinous pericarditis [4] .
Compared to previously published cases, our patient was unusual in that she had relatively longer disease duration of 24 months at diagnosis, she had previously been treated with intravenous cyclophosphamide, and she had no clinical or laboratory evidence of extra-cardiac increased disease activity. Although a low level cANCA level was detected in our patient, this would be considered as normal according to local reference values. The significance of this is unclear as some Wegner's patients experience persistent detectability of cANCA without adverse outcome, whilst up to 20% of patients with limited active disease may have negative levels [15, 16] . Given this uncertainty, we opted to treat her with further immunosuppression on the basis of raised inflammatory markers and cardiac imaging suspicious for granulomatous involvement. However, it is certainly possible that her echocardiographic appearances represented fibrosis rather than active granulomatous disease. The unchanged appearance at follow up may support the latter possibility. On the transthoracic images presented the obvious thickening is of the atrial walls which would not in itself lead to complete AV block, however, she is young and otherwise well and so we would feel that an association between these abnormalities and her presentation is likely. We had hoped to arrange magnetic resonance imaging to try and clarify if disease was also present at the AV node and His conducting tissue, but her need for pacing support prevented this.
In summary, complete AV block is a rare but treatable manifestation of cardiac involvement usually associated with early active systemic disease. All patients diagnosed with Wegener's granulomatosis should be screened with a baseline electrocardiogram and a transthoracic echocardiogram to document cardiac involvement and alert clinicians to those at risk of further cardiac complications. Echocardiography frequently detects abnormalities suggesting cardiac involvement in asymptomatic individuals and this case highlights that later presentation of cardiac abnormalities than previously reported can occur and lifelong surveillance needs to be considered given the poorer prognosis in these individuals. In turn, all patients presenting with cardiac abnormalities and evidence of systemic inflammation should be screened for Wegener's by clinical, laboratory, and radiographic assessment.
